Peptidoglycan synthesis machinery

The peptidoglycan synthesis machinery is a coordinated system of enzymes and transport proteins responsible for building the bacterial cell wall, a structure essential for maintaining cell shape and providing osmotic protection [Typas et al., 2012]. This machinery operates across three cellular compartments: the cytoplasm, where Mur enzymes synthesize precursors; the cytoplasmic membrane, where MraY and MurG form lipid-linked intermediates; and the periplasm, where Penicillin-binding proteins (PBPs) and SEDS proteins perform polymerization and cross-linking [Meeske et al., 2016]. Because peptidoglycan is unique to bacteria and absent in human cells, this machinery is a primary target for many of the most effective antibiotics, including beta-lactams and glycopeptides [StatPearls, 2023]. Drugs targeting this system typically inhibit specific enzymatic steps, leading to a weakened cell wall and subsequent osmotic lysis of the bacterium [PubChem, 2024]. Clinical challenges associated with this target include the rapid evolution of resistance through mechanisms such as beta-lactamase production or target site mutations in PBPs [NIH, 2022]. Understanding the spatial and temporal regulation of this machinery remains crucial for developing next-generation antimicrobials to combat multi-drug resistant pathogens [Nature, 2016]. Overall, the peptidoglycan synthesis machinery represents a cornerstone of antimicrobial chemotherapy due to its high selectivity and essentiality for bacterial viability.

Other names

Bacterial cell wall synthesis machineryMurein biosynthetic pathwayPeptidoglycan biosynthetic pathwayCell wall synthesis machinery

Inhibition of various stages of peptidoglycan assembly, including cytoplasmic precursor synthesis, membrane-associated lipid-linked intermediate formation, and periplasmic polymerization and cross-linking.